In May 2019, we acquired Putnam a U.S.-based strategic management healthcare consultancy. Based in the U.S., Putnam is a specialist consultancy focused on product commercialisation strategy, exclusively for the life sciences industry. Putnam has grown to become a respected advisory brand for biopharmaceutical companies. With over 120 employees across offices in Boston and San Francisco, Putnam offers consultancy services across the product life cycle with particular strengths in product commercialisation, pricing, reimbursement and market access strategy.
Incisive Health is a U.K.-based healthcare communications consultancy, which specialises in healthcare policy, public affairs and communication services. Across its head office in London and an office in Brussels, the consultancy employs 36 people and provides a suite of consultancy and communications services including clinical advocacy, corporate and digital communications, direct payer engagement, public affairs, stakeholder campaigning, strategic and policy development and training programs. Incisive Health has a diversified client base of predominantly pharmaceutical and biotech companies. Both businesses are aligned with our strategy to expand into higher growth and higher margin areas, complementing to our existing service offering.